Epidermolysis bullosa acquisita.
Miyamoto D, Gordilho JO, Santi CG, Porro AM.
An Bras Dermatol. 2022 Jul-Aug;97(4):409-423. doi: 10.1016/j.abd.2021.09.010. Epub 2022 Jun 11.
Epidermolysis Bullosa-A Different Genetic Approach in Correlation with Genetic Heterogeneity.
Pânzaru MC, Caba L, Florea L, Braha EE, Gorduza EV.
Diagnostics (Basel). 2022 May 27;12(6):1325. doi: 10.3390/diagnostics12061325.
[From gene to disease; epidermolysis bullosa due to mutations in proteins in or around the hemidesmosome].
Jonkman MF, Rulo HF, Duipmans JC.
Ned Tijdschr Geneeskd. 2003 Jun 7;147(23):1108-13.
Plectin-related skin diseases.
Natsuga K.
J Dermatol Sci. 2015 Mar;77(3):139-45. doi: 10.1016/j.jdermsci.2014.11.005. Epub 2014 Nov 28.
Recently Identified Forms of Epidermolysis Bullosa.
McGrath JA.
Ann Dermatol. 2015 Dec;27(6):658-66. doi: 10.5021/ad.2015.27.6.658. Epub 2015 Dec 7.
Epidermolysis bullosa: new and emerging trends.
Pai S, Marinkovich MP.
Am J Clin Dermatol. 2002;3(6):371-80. doi: 10.2165/00128071-200203060-00001.
Plectin in Skin Fragility Disorders.
Kiritsi D, Tsakiris L, Schauer F.
Cells. 2021 Oct 14;10(10):2738. doi: 10.3390/cells10102738.
Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.
Evtushenko NA, Beilin AK, Kosykh AV, Vorotelyak EA, Gurskaya NG.
Int J Mol Sci. 2021 Nov 18;22(22):12446. doi: 10.3390/ijms222212446.
Ultrastructure and molecular pathogenesis of epidermolysis bullosa.
Shinkuma S, McMillan JR, Shimizu H.
Clin Dermatol. 2011 Jul-Aug;29(4):412-9. doi: 10.1016/j.clindermatol.2011.01.010.
The pathogeneses of pemphigus and pemphigoid diseases.
Ujiie H, Yamagami J, Takahashi H, Izumi K, Iwata H, Wang G, Sawamura D, Amagai M, Zillikens D.
J Dermatol Sci. 2021 Dec;104(3):154-163. doi: 10.1016/j.jdermsci.2021.11.003.
